AIDS and Behavior

, Volume 18, Issue 5, pp 905–912

Incentivizing HIV/STI Testing: A Systematic Review of the Literature

  • Ramon Lee
  • Rosa R. Cui
  • Kathryn E. Muessig
  • Harsha Thirumurthy
  • Joseph D. Tucker
Substantive Review

Abstract

Suboptimal HIV/STI testing uptake has a profound impact on morbidity and mortality. Incentives have been effective in other areas of medicine and may improve HIV/STI testing uptake rates. This study reviewed the effects of incentives on HIV/STI testing uptake. A systematic search of seven databases was undertaken. Testing uptake was defined as test implementation and/or test result retrieval. Incentives were defined as monetary or non-monetary rewards or free-of-charge testing vouchers. Seven studies were included. All seven studies demonstrated higher rates of uptake in an incentivized group. Incentives offered at a non-clinical setting demonstrated more significant differences in uptake rates compared to incentives offered at a clinical setting. Incentivizing HIV/STI testing uptake, especially testing at a non-clinical setting, may be a useful tool to modify health behavior. Further research is needed to understand how incentives could be an effective component within a comprehensive HIV/STI control strategy.

Keywords

HIV/AIDS Sexually transmitted diseases Incentive Conditional cash transfer Voucher Contingency management 

Supplementary material

10461_2013_588_MOESM1_ESM.docx (11 kb)
Supplementary material 1 (DOCX 10 kb)

References

  1. 1.
    World Health Organization. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Geneva: WHO Press; 2009.Google Scholar
  2. 2.
    Cherutich P, Bunnell R, Mermin J. HIV testing: current practice and future directions. Curr HIV/AIDS Rep. 2013;10(2):134–41.PubMedCrossRefGoogle Scholar
  3. 3.
    Hogg RS, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 1998;279(6):450–4.PubMedCrossRefGoogle Scholar
  4. 4.
    Rothman RE. Current Centers for Disease Control and Prevention guidelines for HIV counseling, testing, and referral: critical role of and a call to action for emergency physicians. Ann Emerg Med. 2004;44(1):31–42.PubMedCrossRefGoogle Scholar
  5. 5.
    Gullette DL, Rooker JL, Kennedy RL. Factors associated with sexually transmitted infections in men and women. J Community Health Nurs. 2009;26(3):121–30.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Ellen JM, et al. An investigation of geographic clustering of repeat cases of gonorrhea and chlamydial infection in San Francisco, 1989–1993: evidence for core groups. J Infect Dis. 1997;175(6):1519–22.PubMedCrossRefGoogle Scholar
  7. 7.
    O’Donoghue T, Rabin M. Doing it now or later. Am Econ Rev. 1999;89(1):103–24.CrossRefGoogle Scholar
  8. 8.
    Ranganathan M, Lagarde M. Promoting healthy behaviours and improving health outcomes in low and middle income countries: a review of the impact of conditional cash transfer programmes. Prev Med. 2012;55(Suppl):S95–105.PubMedCrossRefGoogle Scholar
  9. 9.
    de Walque D, et al. Incentivising safe sex: a randomised trial of conditional cash transfers for HIV and sexually transmitted infection prevention in rural Tanzania. BMJ Open. 2012;2:e000747.PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Baird SJ, et al. Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial. Lancet. 2012;1320–9.Google Scholar
  11. 11.
    Malotte CK, Hollingshead JR, Rhodes F. Monetary versus nonmonetary incentives for TB skin test reading among drug users. Am J Prev Med. 1999;16(3):182–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Malotte CK, Rhodes F, Mais KE. Tuberculosis screening and compliance with return for skin test reading among active drug users. Am J Public Health. 1998;88(5):792–6.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Pilling S, et al. Psychosocial interventions and opioid detoxification for drug misuse: summary of NICE guidance. BMJ. 2007;335(7612):203–5.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Lussier JP, et al. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction. 2006;101:192–203.PubMedCrossRefGoogle Scholar
  15. 15.
    Budney AJ, et al. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol. 2000;68(6):1051–61.PubMedCrossRefGoogle Scholar
  16. 16.
    Volpp KG, et al. A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med. 2009;360(7):699–709.PubMedCrossRefGoogle Scholar
  17. 17.
    Lagarde M, Haines A, Palmer N. Conditional cash transfers for improving uptake of health interventions in low- and middle-income countries: a systematic review. JAMA. 2007;298(16):1900–10.PubMedCrossRefGoogle Scholar
  18. 18.
    Handa S, Davis B. The experience of conditional cash transfers in Latin America and the Caribbean. Dev Policy Rev. 2006;24(5):513–36.CrossRefGoogle Scholar
  19. 19.
    Nguyen HT, et al. Encouraging maternal health service utilization: an evaluation of the Bangladesh voucher program. Soc Sci Med. 2012;74(7):989–96.PubMedCrossRefGoogle Scholar
  20. 20.
    de Savigny D, et al. Introducing vouchers for malaria prevention in Ghana and Tanzania: context and adoption of innovation in health systems. Health Policy Plan. 2012;27(Suppl 4):iv32–43.PubMedCrossRefGoogle Scholar
  21. 21.
    Owens DK, et al. AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions—agency for healthcare research and quality and the effective health-care program. J Clin Epidemiol. 2010;63(5):513–23.Google Scholar
  22. 22.
    Chacko MR, et al. Failure of a lottery incentive to increase compliance with return visit for test-of-cure culture for Neisseria gonorrhoeae. Sex Transm Dis. 1987;14(2):75–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Geringer WM, Hinton M. Three models to promote syphilis screening and treatment in a high risk population. J Community Health. 1993;18(3):137–51.PubMedCrossRefGoogle Scholar
  24. 24.
    Malotte CK, et al. Comparison of methods to increase repeat testing in persons treated for gonorrhea and/or chlamydia at public sexually transmitted disease clinics. Sex Transm Dis. 2004;31(11):637–42.PubMedCrossRefGoogle Scholar
  25. 25.
    Haukoos JS, et al. The effect of financial incentives on adherence with outpatient human immunodeficiency virus testing referrals from the emergency department. Acad Emerg Med. 2005;12(7):617–21.PubMedCrossRefGoogle Scholar
  26. 26.
    Thornton RL. The demand for, and impact of learning HIV status. Am Econ Rev. 2008;98(5):1829–63.PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Currie MJ, et al. ‘Show me the money’: financial incentives increase chlamydia screening rates among tertiary students: a pilot study. Sex Health. 2010;7(1):60–5.PubMedCrossRefGoogle Scholar
  28. 28.
    Nglazi MD, et al. An incentivized HIV counseling and testing program targeting hard-to-reach unemployed men in Cape Town, South Africa. J Acquir Immune Defic Syndr. 2012;59(3):e28–34.PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    World Bank's Development Data Group. Country and Lending Groups. 2012. http://data.worldbank.org/about/country-classifications/country-and-lending-groups.
  30. 30.
    Pettifor A, et al. Can money prevent the spread of HIV? A review of cash payments for HIV prevention. AIDS Behav. 2012;16(7):1729–38.PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Haug NA, Sorensen JL. Contingency management interventions for HIV-related behaviors. Curr HIV/AIDS Rep. 2006;3(4):154–9.PubMedCrossRefGoogle Scholar
  32. 32.
    Galarraga O, et al. Conditional economic incentives to improve HIV treatment adherence: literature review and theoretical considerations. AIDS Behav. 2013;17(7):2283–92.Google Scholar
  33. 33.
    Sutherland K, Leatherman S, Christianson J. Paying the patient: does it work? Quest Qual Improv Perform. 2008.Google Scholar
  34. 34.
    Jeffery RW. Financial incentives and weight control. Prev Med. 2012;55(Suppl):S61–7.PubMedCentralPubMedCrossRefGoogle Scholar
  35. 35.
    Giuffrida A, Torgerson DJ. Should we pay the patient? Review of financial incentives to enhance patient compliance. BMJ. 1997;315(7110):703–7.PubMedCentralPubMedCrossRefGoogle Scholar
  36. 36.
    Holmes K. Sexually transmitted diseases. 4th ed. New York: McGraw-Hill Professional; 2007. p. 2192.Google Scholar
  37. 37.
    Loewenstein G. Asymmetric paternalism to improve health behaviors. JAMA. 2007;298(20):2.CrossRefGoogle Scholar
  38. 38.
    Deren S, et al. The impact of providing incentives for attendance at AIDS prevention sessions. Public Health Rep. 1994;109(4):548–54.PubMedCentralPubMedGoogle Scholar
  39. 39.
    Carey MP, et al. Recruiting patients from a sexually transmitted disease clinic to sexual risk reduction workshops: are monetary incentives necessary? J Public Health Manag Pract. 2005;11(6):516–21.PubMedCentralPubMedCrossRefGoogle Scholar
  40. 40.
    Meuwissen LE, et al. Uncovering and responding to needs for sexual and reproductive health care among poor urban female adolescents in Nicaragua. Trop Med Int Health. 2006;11(12):1858–67.PubMedCrossRefGoogle Scholar
  41. 41.
    Corbett EL, et al. Uptake of workplace HIV counselling and testing: a cluster-randomised trial in Zimbabwe. PLoS Med. 2006;3(7):e238. doi:10.1371/journal.pmed.0030238.
  42. 42.
    Lugada E, et al. Comparison of home and clinic-based HIV testing among household members of persons taking antiretroviral therapy in Uganda: results from a randomized trial. J Acquir Immune Defic Syndr. 2010;55(2):245–52.PubMedCrossRefGoogle Scholar
  43. 43.
    Beyrer C, et al. Expanding the space: inclusion of most-at-risk populations in HIV prevention, treatment, and care services. J Acquir Immune Defic Syndr. 2011;57(Suppl 2):S96–9.PubMedCentralPubMedCrossRefGoogle Scholar
  44. 44.
    Tucker JD, et al. Social entrepreneurship for sexual health (SESH): a new approach for enabling delivery of sexual health services among most-at-risk populations. PLoS Med. 2012;9(7):e1001266.PubMedCentralPubMedCrossRefGoogle Scholar
  45. 45.
    Tucker JD, Bien CH, Peeling RW. Point-of-care testing for sexually transmitted infections: recent advances and implications for disease control. Curr Opin Infect Dis. 2013;26(1):73–9.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Ramon Lee
    • 1
  • Rosa R. Cui
    • 2
  • Kathryn E. Muessig
    • 3
  • Harsha Thirumurthy
    • 4
  • Joseph D. Tucker
    • 5
  1. 1.Harvard Medical SchoolBostonUSA
  2. 2.Columbia University College of Physicians and SurgeonsNew YorkUSA
  3. 3.Department of Health Behavior, Gillings School of Global Public HealthUniversity of North Carolina at Chapel HillChapel HillUSA
  4. 4.Department of Health Policy and Management, Gillings School of Global Public HealthUniversity of North Carolina at Chapel HillChapel HillUSA
  5. 5.UNC Project-China, School of MedicineUniversity of North Carolina at Chapel HillChapel HillUSA

Personalised recommendations